Patents Assigned to SHENZHEN BOLAN PHARMACEUTICAL CO., LTD
  • Crystalline form of lenvatinib mesylate and methods thereof
    Patent number: 11059787
    Abstract: The present invention provides a novel crystalline form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate (i.e., lenvatinib mesylate) and pharmaceutical compositions thereof. Methods of preparing such a crystalline form and uses in treatment are also provided.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: July 13, 2021
    Assignee: SHENZHEN BOLAN PHARMACEUTICAL CO., LTD
    Inventor: Xiangguang Xiao